Nanosized bioceramic particles could function as efficient gene delivery vehicles with target specificity for the spleen
暂无分享,去创建一个
P. Lam | P. Cheang | K. Hui | Kam M. Hui | P Cheang | I. Ho | K Tan | I A W Ho | P Y P Lam | K M Hui | K. Tan
[1] R. Mebius,et al. Structure and function of the spleen , 2005, Nature Reviews Immunology.
[2] Leaf Huang,et al. LPD nanoparticles--novel nonviral vector for efficient gene delivery. , 2002, Methods in molecular medicine.
[3] M. Hashida,et al. Pharmacokinetics of Plasmid DNA-Based Non-viral Gene Medicine. , 2005, Advances in genetics.
[4] H. Lipps,et al. Designing nonviral vectors for efficient gene transfer and long-term gene expression. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] J. Behr,et al. Development of plasmid and oligonucleotide nanometric particles , 2002, Gene Therapy.
[6] R. DeMatteo,et al. In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] I. Khalil,et al. Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery , 2006, Pharmacological Reviews.
[8] M. Bureau,et al. Non-viral gene transfer of murine spleen cells achieved by in vivo electroporation , 2003, Gene Therapy.
[9] Kinam Park,et al. Polycation gene delivery systems: escape from endosomes to cytosol , 2003, The Journal of pharmacy and pharmacology.
[10] Ronald G. Crystal,et al. Genetic medicines: treatment strategies for hereditary disorders , 2006, Nature Reviews Genetics.
[11] T C Yih,et al. Engineered nanoparticles as precise drug delivery systems , 2006, Journal of cellular biochemistry.
[12] G. Georgiev,et al. Gene transfer approaches in cancer immunotherapy , 2004, Gene therapy.
[13] A. Kondo,et al. Nanoparticles for the delivery of genes and drugs to human hepatocytes , 2003, Nature Biotechnology.
[14] R. DeMatteo,et al. Natural Killer Dendritic Cells Have Both Antigen Presenting and Lytic Function and in Response to CpG Produce IFN-γ via Autocrine IL-121 , 2005, The Journal of Immunology.
[15] A. Logan,et al. Barriers to gene delivery using synthetic vectors. , 2005, Advances in genetics.
[16] K. Niihara,et al. Wear properties of alumina/zirconia composite ceramics for joint prostheses measured with an end-face apparatus. , 2004, Bio-medical materials and engineering.
[17] K. Hui,et al. Generation of potent and specific cellular immune responses via in vivo stimulation of dendritic cells by pNGVL3-hFLex plasmid DNA and immunogenic peptides , 2002, Gene Therapy.
[18] E. Wagner,et al. Targeted nucleic acid delivery into tumors: new avenues for cancer therapy. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[19] D. Luo,et al. A self-assembled, modular DNA delivery system mediated by silica nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[20] Y. Byun,et al. Low molecular weight protamine: a potential nontoxic heparin antagonist. , 1999, Thrombosis research.
[21] Dan Luo,et al. Cellular Fate of a Modular DNA Delivery System Mediated by Silica Nanoparticles , 2008, Biotechnology progress.
[22] H. Lipps,et al. Towards safe, non-viral therapeutic gene expression in humans , 2005, Nature Reviews Genetics.
[23] M. Davis,et al. Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration. , 2001, Current opinion in molecular therapeutics.
[24] K. Khor,et al. Temperature driven morphological changes of chemically precipitated hydroxyapatite nanoparticles. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[25] K. Hui,et al. Intramuscular immunization with plasmid coexpressing tumour antigen and Flt-3L results in potent tumour regression , 2006, Gene Therapy.
[26] Wim E. Hennink,et al. Artificial viruses: a nanotechnological approach to gene delivery , 2006, Nature Reviews Drug Discovery.
[27] K. Khor,et al. Radio frequency (RF) suspension plasma sprayed ultra-fine hydroxyapatite (HA)/zirconia composite powders. , 2003, Biomaterials.
[28] C. Lawson. Strategies for Gene Transfer to Solid Organs , 2006 .
[29] T. Niidome,et al. Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.
[30] Yong Wang,et al. Delivery of Viral Vectors to Tumor Cells: Extracellular Transport, Systemic Distribution, and Strategies for Improvement , 2006, Annals of Biomedical Engineering.